Long term graft and patient outcomes in highly-HLA sensitized (HS) patients desensitized with high dose (HD) IVIG

被引：0
|
作者：
Peng, Alice [1 ]
Vo, Ashley [1 ]
Villicana, Rafael [1 ]
Lee, Richard [1 ]
Dafoe, Donald [1 ]
Reinsmoen, Nancy [1 ]
Skinner, Edwina [1 ]
Jordan, Stanley [1 ]
机构：
[1] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [1] Long term graft and patient outcomes in highly-HLA sensitized (HS) deceased donor (DD) kidney transplant (KT) recipients desensitized with high dose (HD) IVIG.
    Peng, Alice
    Vo, Ashley
    Villicana, Rafael
    Dafoe, Donald
    Reinsmoen, Nancy
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 303 - 303
  • [2] Long Term Outcomes of Deceased Donor (DD) Transplants in Highly-HLA Sensitized Patients (HS) Desensitized with IVIG plus Single-Dose (SD) Rituximab.
    Vo, Ashley A.
    Toyoda, Mieko
    Ge, Shili
    Lai, Chih-Hung
    Cao, Kai
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 561 - 562
  • [3] Long Term Outcomes in Highly-HLA Sensitized (HS) Patients Receiving Desensitization with IVIG and Single-Dose (SD) Rituximab.
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 557 - 557
  • [4] HLA Mismatching Has No Significant Impact on Kidney Transplant Outcomes of Highly-HLA Sensitized Patients Desensitized with IVIG ± Rituximab.
    Cao, Kai
    Vo, Ashley A.
    Lai, Chih-Hung
    Wang, Qi
    Ong, Geraldine
    Mehrnoush, Naim
    Jordan, Stanley C.
    Reinsmoen, Nancy L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 561 - 561
  • [5] Long Term Outcomes of Highly-HLA Sensitized (PRA>80%) ( HS) Patients Receiving Desensitization with IVIG or IVIG plus Rituximab: A Retrospective, Single-Center Analysis
    Vo, A.
    Choi, J.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Najjar, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 284 - 284
  • [6] Analysis of Subcutaneous (SQ) Campath 1-H Induction Therapy in Highly-HLA Sensitized (HS) Patients Desensitized with IVIG plus Rituximab: Three Year Outcomes.
    Vo, Ashley A.
    Mieko, Toyoda
    Ge, Shili
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 370 - 370
  • [7] IVIG plus single-dose rituximab is an effective desensitization strategy for highly-HLA sensitized patients
    Vo, Ashley A.
    Cao, Kai
    Lai, Chih-Hung
    Reinsmoen, Nancy
    Toyoda, Mieko
    Ge, Shili
    Peng, Alice
    Villicana, Rafael
    Kahwaji, Joseph
    Jordan, Stanley C.
    XENOTRANSPLANTATION, 2009, 16 (05) : 333 - 333
  • [8] Rates of acute rejection (AR) and treatment outcomes in highly-HLA sensitized patients (HS) transplanted after desensitization with IVIG plus rituximab
    Lee, Richard
    Peng, Alice
    Villicana, Rafael
    Vo, Ashley
    Dafoe, Donald
    Chang, Robert
    Toyoda, Mieko
    Reinstroen, Nancy
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 238 - 238
  • [9] Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation.
    Vo, A. A.
    Huang, E.
    Williamsons, S.
    Myers, C.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Lim, K.
    Ammerman, N.
    Gordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 812 - 813
  • [10] Use of IVIG plus single dose rituximab for desensitization of highly-HLA sensitized patients awaiting kidney transplantation
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 181 - 181
12345